Paving the way for ctDNA-guided trials in lung cancer: insights from the LIBELULE study
- PMID: 40673080
- PMCID: PMC12261362
- DOI: 10.21037/tlcr-2025-427
Paving the way for ctDNA-guided trials in lung cancer: insights from the LIBELULE study
Keywords: Liquid biopsy (LB); non-small cell lung cancer (NSCLC); rapid precision diagnostics.
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-2025-427/coif). A.R.D. reports lecture fees and/or consulting fees from MSD, Roche, BMS and Takeda. The other author has no conflicts of interest to declare.
Comment on
-
LIBELULE: A Randomized Phase III Study to Evaluate the Clinical Relevance of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer.J Thorac Oncol. 2025 Apr;20(4):437-450. doi: 10.1016/j.jtho.2024.12.011. Epub 2024 Dec 16. J Thorac Oncol. 2025. PMID: 39694415 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources